Business
SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating
DALLAS & LYON, France, May 05, 2026--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, announced today that Portzamparc, a subsidiary of the BNP Paribas Group specializing in equity research and invest
About this update from S.m.a.i.o S.a.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":377,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/ade5d69e89356cbe28beb0514746fc6c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CDCcrzypXHZZGC6nVeRT4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTg5OA--/https://media.zenfs.com/en/business-wire.com/ade5d69e89356cbe28beb0514746fc6c","width":377,"height":480}},"lazy":false},{"type":"text","content":"DALLAS & LYON, France, May 05, 2026--(BUSINESS WIRE)--Regulatory News:","length":74,"tagName":"p"},{"type":"text","content":"SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, announced today that Portzamparc, a subsidiary of the BNP Paribas Group specializing in equity research and investment banking services for Small & Mid-cap companies, has initiated coverage of its stock.","length":539,"tagName":"p"},{"type":"text","content":"In its initial coverage report, titled "A Lyon-based tailor offering bespoke solutions for your back" and published on May 5, 2026, Portzamparc initiated coverage of the stock with a Buy recommendation and valued the company at €8.80 per share1.","length":255,"tagName":"p"},{"type":"text","content":"The SMAIO stock is now covered by three equity research firms: Portzamparc (BNP Paribas Group), EuroLand Corporate and TP ICAP.","length":127,"tagName":"p"},{"type":"text","content":"Upcoming financial event:","length":25,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"First-quarter 2026 sales: May 12, 2026 (after market)","length":53,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":53,"olType":false},{"type":"text","content":"About SMAIO","length":11,"tagName":"p"},{"type":"text","content":"A precursor in the use of clinical data and imaging of the spine, SMAIO designs global solutions for spine surgery specialists. The Company has recognized expertise thanks to its big data database, which has become a global reference with more than 100,000 patient cases documented. SMAIO ...